"All parties agreed there was a strong strategic and cultural alignment which we believe makes [Paul Schreier] exceptionally well-placed to lead SimplyHealth."
- Mike Hall, SimplyHealth’s Chairman
Prior to this appointment, Paul Schreier led the Wellcome Trust’s COVID-19 treatment campaign with led to his appointment as Global Therapeutics Co-Lead of the World Health Organisation’s (WHO) accelerating COVID-19 tools partnership - this involved several other multilateral agencies. As Interim CEO of the Wellcome Trust, he also served as a member of the investment committee which oversaw the charity’s substantial investment activities.
Paul is set to join SimplyHealth in mid-May, replacing Nicholas Potter who will continue in his previous role of Chief Financial Officer.
“I’m absolutely delighted to be joining SimplyHealth and very much look forward to leading the company at this pivotal time in our country’s history, when improving access to healthcare has never been more important,” he said. Paul believes the company has an “amazing opportunity to make a difference to the health of people across the UK.”
Mike Hall, SimplyHealth’s Chairman, thanked Nicholas for stepping up and taking on the role of Acting CEO for the last twelve months, as well as his continued efforts to assist with the delivery of low-cost, accessible, quality healthcare. “Paul has a truly impressive professional background and throughout the recruitment process, all parties agreed there was a strong strategic and cultural alignment which we believe makes him exceptionally well-placed to lead SimplyHealth,” he concluded.
